
North America Joint Reconstruction Devices Market Outlook (2022-2033)
No. of Pages: 150 | Report Code: BMIPUB00031878 | Category: Life Sciences
No. of Pages: 150 | Report Code: BMIPUB00031878 | Category: Life Sciences
The joint reconstruction devices market size is expected to reach US$ 15,265.80 million by 2033 from US$ 10,186.62 million in 2024. The market is estimated to record a CAGR of 4.7% from 2025 to 2033.
North America's joint reconstruction devices market is one of the most advanced and mature globally due to its healthcare infrastructures, higher procedural volumes, and demand for new orthopedic solutions. The United States itself is a leader in joint reconstruction, representing a large portion of all surgical procedures globally, owing to its huge aging population, a high number of arthritis patients, and extensive insurance coverage. Canada is also an important contributor to the North American market, with Public Health Insurance coverage ensuring most patients have access to joint reconstruction procedures. North America also leads the market regarding new technologies (e.g., robotic-assisted surgery, 3D printed implants, smart joints), and innovation fuelled by collaboration among healthcare providers, universities, research institutions, and MedTech companies to enhance treatment options for joint reconstruction. The demand is there as patient awareness continues to rise; with an increased emphasis on being active, getting surgery sooner & smarter (with the assisted technology) & focusing on quicker recovery times and long-term outcomes, the joint reconstruction market will continue to grow. With continued investment & commitment & strong clinical expertise, North America will continue to represent a global benchmark in joint reconstruction care.
Key segments that contributed to the derivation of the joint reconstruction devices market analysis are product type, fixation type, material type, surgery type, and end user
In the global joint reconstruction devices market, North America emerges as the foremost region. The dynamics of the market are provided by the presence of well-established health care systems with a high degree of awareness regarding patient needs and unimaginable access to surgical care. Increasingly common joint replacement activities, especially for knees and hips, due to aging populace, joint disorders, and appeasement conditions, act as the major growth-driver in the market. For instance, according to the report published in September 2024 by American Association of Hip and Knee Surgeons (AAHKS), the total number of hip replacement procedures in U.S. were 763,691 in 2022 which increased to 793,082 in 2023, marking a 3.8% growth. Similarly, knee surgeries experienced an even stronger upward trend, with the total number increasing from 1,293,438 in 2022 to in 2023, a 5.1% jump.
Based on region, the North America joint reconstruction devices Market is further segmented into the United States, Canada and Mexico. The United States held the largest share in 2024.
The market is being driven by increased awareness of joint health issues, an aging population, and a strong emphasis on remaining physically active in albeit in older age. In addition, we have many top medical device companies in the market, many of which are based in the US, ever committed to innovation in providing improved and more comfortable joint reconstruction solutions. The market also benefits from strong regulatory support, liberal reimbursement schemes, and skilled cadre of orthopedic surgeons. For instance, in February 2024, Smith & Nephew Plc. the global medical technology company, announced the commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use with ATLASPLAN 3D Planning Software and Patient Specific Instrumentation for total shoulder arthroplasty.
Overall, the market remains both active and competitive. Even if the U.S. market is mature, it continues to respond to innovation, meets patient demand through new procedures and implants/personalized approaches. There has been a notable shift towards minimally invasive procedures and devices that advance joint function and speed up the healing process, either through design or new forms of therapy.
Report Attribute | Details |
---|---|
Market size in 2024 | US$ 10,186.62 Million |
Market Size by 2033 | US$ 15,265.80 Million |
Global CAGR (2025 - 2033) | 4.7% |
Historical Data | 2022-2023 |
Forecast period | 2025-2033 |
Segments Covered |
By Product Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Stryker, Zimmer Biomet, Johnson & Johnson, Smith & Nephew, B. Braun SE, Exactech Inc., Globus Medical Inc., Enovis Corporation, MicroPort Scientific Corporation, and Meril Life are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.
The following methodology has been followed for the collection and analysis of data presented in this report:
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.
The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:
Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:
The North America Joint Reconstruction Devices Market is valued at US$ 10,186.62 Million in 2024, it is projected to reach US$ 15,265.80 Million by 2033.
As per our report North America Joint Reconstruction Devices Market, the market size is valued at US$ 10,186.62 Million in 2024, projecting it to reach US$ 15,265.80 Million by 2033. This translates to a CAGR of approximately 4.7% during the forecast period.
The North America Joint Reconstruction Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Joint Reconstruction Devices Market report:
The North America Joint Reconstruction Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Joint Reconstruction Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Joint Reconstruction Devices Market value chain can benefit from the information contained in a comprehensive market report.